Michigan Biomedical Venture Fund
The Michigan Biomedical Venture Fund (MBVF) invests in biomedical startup companies with U-M licensed IP in the domain of therapeutics, devices, diagnostics, or health IT.
Michigan Drug Discovery
Supporting and facilitating drug discovery programs led by faculty at the University of Michigan.
Michigan Institute for Clinical & Health Research
The Michigan Institute for Clinical & Health Research (MICHR) is here to enable & enhance clinical & translational research at U-M. We do this by being a catalytic partner that educates, funds, connects & supports research teams here and beyond. Think of our helpful and knowledgeable staff and faculty as your extended research team.
Material Transfer Agreement – Incoming
Incoming Material Transfer Agreements (MTA) govern the transfer of material from outside entities to U-M.
If you are an outside entity interested in sending material to a researcher at U-M, please contact
[email protected] and provide information about the materials and the recipient.
Regents Bylaw 3.10
Sec. 3.10 of the Bylaws of The Board of Regents: Ownership of Patents, Copyrights, Computer Software, and Other Property Rights.
Research Activity and Compliance
Because of the complex nature of the university’s work in a wide range of areas, there are many compliance requirements that intersect with individual activities and roles in different ways.
Research Catalyst and Innovation Program
The Research Catalyst and Innovation (RCI) Program includes four new funding mechanisms totaling more than $1.5 million in annual support.
The program infuses funding and fosters increased collaboration to catalyze research and spur innovation across the three University of Michigan campuses.
Research Tools
To accelerate scientific discoveries and to benefit the greater research community, principal investigators and funding recipient institutions are expected to ensure broad and timely dissemination of their research resources.
SPARC – University of Michigan Partnership Grant for Drug Discovery
SPARC – University of Michigan Partnership Grant for Drug Discovery seeks to provide financial support and in-kind industry resources to move various promising drug-discovery research projects within the university toward the ultimate goal of new therapies for patients.
Tax Considerations
The University of Michigan’s policy on the distribution of tech transfer licensing revenues provides that a percentage of net revenues are shared with U-M employees that are inventors or developers (“inventors”) of the licensed patent rights, materials, software, or other licensed inventions. Occasionally, a U-M inventor will desire to redirect (or “waive”) all or a portion of his or her share of revenues to a U-M entity.
University Policy on Intellectual Property and Commercialization
This Policy implements Section 3.10 of the Bylaws of the Board of Regents. The Policy further defines the ownership, distribution, and commercialization of rights associated with Intellectual Property developed at or received by the University of Michigan, and describes the general obligations associated with the technology licensing process.
